This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mauad, T. H. Articles by Oude Elferink, R. P. Search for Related Content PubMed PubMed Citation Articles by Mauad, T. H. Articles by Oude Elferink, R. P.

American Journal of Pathology, Vol 145, 1237-1245, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis

TH Mauad, CM van Nieuwkerk, KP Dingemans, JJ Smit, AH Schinkel, RG Notenboom, MA van den Bergh Weerman, RP Verkruisen, AK Groen and RP Oude Elferink
Department of Pathology (H2), Academic Medical Center, Amsterdam, The Netherlands.

The mouse mdr2 gene (and its human homologue MDR3, also called MDR2) encodes a P-glycoprotein that is present in high concentration in the bile canalicular membrane of hepatocytes. The 129/OlaHsd mice with a homozygous disruption of the mdr2 gene (-/- mice) lack this P- glycoprotein in the canalicular membrane. These mice are unable to secrete phospholipids into bile, showing an essential role for the mdr2 P-glycoprotein in the transport of phosphatidylcholine across the canalicular membrane. The complete absence of phospholipids from bile leads to a hepatic disease, which becomes manifest shortly after birth and shows progression to an end stage in the course of 3 months. The liver pathology is that of a nonsuppurative inflammatory cholangitis with portal inflammation and ductular proliferation, consistent with toxic injury of the biliary system from bile salts unaccompanied by phospholipids. Thus, the mdr2 (-/-) mice can serve as an animal model for studying mechanisms and potential interventions in nonsuppurative inflammatory cholangitis (in a generic sense) in human disease, be it congenital or acquired. When the mice are 4 to 6 months of age, preneoplastic lesions develop in the liver, progressing to metastatic liver cancer in the terminal phase. The mdr2 (-/-) mice therefore also provide a tumor progression model of value for the study of hepatic carcinogenesis. Interestingly, also in this regard, the model mimicks human disease, because chronic inflammation of the biliary system in humans may similarly carry increased cancer risk.

This article has been cited by other articles:

				F. Marongiu, S. Doratiotto, S. Montisci, P. Pani, and E. Laconi Liver Repopulation and Carcinogenesis: Two Sides of the Same Coin? Am. J. Pathol., April 1, 2008; 172(4): 857 - 864. [Abstract] [Full Text] [PDF]

				M. Katzenellenbogen, L. Mizrahi, O. Pappo, N. Klopstock, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, E. Domany, E. Galun, et al. Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice Mol. Cancer Res., November 1, 2007; 5(11): 1159 - 1170. [Abstract] [Full Text] [PDF]

				I. Kim, K. Morimura, Y. Shah, Q. Yang, J. M. Ward, and F. J. Gonzalez Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice Carcinogenesis, May 1, 2007; 28(5): 940 - 946. [Abstract] [Full Text] [PDF]

				M. Katzenellenbogen, L. Mizrahi, O. Pappo, N. Klopstock, D. Olam, H. Barash, E. Domany, E. Galun, and D. Goldenberg Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice Mol. Cancer Ther., April 1, 2007; 6(4): 1283 - 1291. [Abstract] [Full Text] [PDF]

				F. Yang, X. Huang, T. Yi, Y. Yen, D. D. Moore, and W. Huang Spontaneous Development of Liver Tumors in the Absence of the Bile Acid Receptor Farnesoid X Receptor Cancer Res., February 1, 2007; 67(3): 863 - 867. [Abstract] [Full Text] [PDF]

				T. Sakurai, S. Maeda, L. Chang, and M. Karin Inaugural Article: Loss of hepatic NF-{kappa}B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation PNAS, July 11, 2006; 103(28): 10544 - 10551. [Abstract] [Full Text] [PDF]

				M. Katzenellenbogen, O. Pappo, H. Barash, N. Klopstock, L. Mizrahi, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, L. A. Mitchell, et al. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the mdr2-knockout mice. Cancer Res., April 15, 2006; 66(8): 4001 - 4010. [Abstract] [Full Text] [PDF]

				J.-S. Lee, J. W. Grisham, and S. S. Thorgeirsson Comparative functional genomics for identifying models of human cancer Carcinogenesis, June 1, 2005; 26(6): 1013 - 1020. [Abstract] [Full Text] [PDF]

				J. Shoda, Y. Inada, A. Tsuji, H. Kusama, T. Ueda, T. Ikegami, H. Suzuki, Y. Sugiyama, D. E. Cohen, and N. Tanaka Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPAR{alpha}-mediated redistribution of ABCB4 J. Lipid Res., October 1, 2004; 45(10): 1813 - 1825. [Abstract] [Full Text] [PDF]

				R. P. J. O. Elferink, R. Ottenhoff, G. Fricker, D. J. Seward, N. Ballatori, and J. Boyer Lack of biliary lipid excretion in the little skate, Raja erinacea, indicates the absence of functional Mdr2, Abcg5, and Abcg8 transporters Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G762 - G768. [Abstract] [Full Text] [PDF]

				M. Trauner and J. L. Boyer Bile Salt Transporters: Molecular Characterization, Function, and Regulation Physiol Rev, April 1, 2003; 83(2): 633 - 671. [Abstract] [Full Text] [PDF]

				C. W.T. van Roermund, H. F. Tabak, M. van den Berg, R. J.A. Wanders, and E. H. Hettema Pex11p Plays a Primary Role in Medium-Chain Fatty Acid Oxidation, a Process that Affects Peroxisome Number and Size in Saccharomyces cerevisiae J. Cell Biol., August 7, 2000; 150(3): 489 - 498. [Abstract] [Full Text] [PDF]

				L. Amigo, H. Mendoza, S. Zanlungo, J. F. Miquel, A. Rigotti, S. González, and F. Nervi Enrichment of canalicular membrane with cholesterol and sphingomyelin prevents bile salt-induced hepatic damage J. Lipid Res., March 1, 1999; 40(3): 533 - 542. [Abstract] [Full Text]

				J. M. L. de Vree, E. Jacquemin, E. Sturm, D. Cresteil, P. J. Bosma, J. Aten, J.-F. Deleuze, M. Desrochers, M. Burdelski, O. Bernard, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis PNAS, January 6, 1998; 95(1): 282 - 287. [Abstract] [Full Text] [PDF]

				A. J. Smith, A. van Helvoort, G. van Meer, K. Szabo, E. Welker, G. Szakacs, A. Varadi, B. Sarkadi, and P. Borst MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping J. Biol. Chem., July 28, 2000; 275(31): 23530 - 23539. [Abstract] [Full Text] [PDF]